US 7781175
Method of screening compounds which alter the binding properties of GPR39, and homologs thereof, to bile acid
granted A61PA61P1/00A61P1/08
Quick answer
US patent 7781175 (Method of screening compounds which alter the binding properties of GPR39, and homologs thereof, to bile acid) held by Takeda Pharmaceutical Company Limited expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P1/00, A61P1/08, A61P29/00, A61P3/06